SCHEMBL13638287

SCHEMBL13638287

C=C1CC(Nc2nccc(-c3ccc(C4(O)CCN(C)CC4)s3)n2)CC(C)(C)N1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 7/20 0.37
CCND1 P24385 6/20 0.37
CDK1 P06493 5/20 0.37
CCNB1 P14635 5/20 0.37
CCNA2 P20248 5/20 0.37
CDK2 P24941 5/20 0.37
CCNA1 P78396 3/20 0.37
IKBKB O14920 4/20 0.37
CCND3 P30281 4/20 0.37
CDK6 Q00534 4/20 0.37
RET P07949 1/20 0.35
MAPK8 P45983 2/20 0.35
KCNH2 Q12809 1/20 0.35
MAPK9 P45984 2/20 0.35
MAPK10 P53779 1/20 0.35
HRH4 Q9H3N8 1/20 0.33
CCNT1 O60563 2/20 0.32
CDK7 P50613 2/20 0.32
CDK9 P50750 2/20 0.32
CCNH P51946 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3478504 0.87 IKBKB (0.41) CDK4CCND1CDK1CCNB1CCNA2
SCHEMBL14612786 0.85 IKBKB (0.46) CDK4CCND1CDK1CCNB1CCNA2
SCHEMBL13638454 0.80 CDK4 (0.36) CDK4CCND1CDK1CCNB1CCNA2
SCHEMBL14612785 0.80 IKBKB (0.37) CDK4CCND1CDK1CCNB1CCNA2
SCHEMBL13638461 0.80 AKT3 (0.32) CDK4CCND1CDK1CCNB1CCNA2
SCHEMBL13638669 0.80 CDK2 (0.36) CDK4CCND1CDK1CCNB1CCNA2
SCHEMBL13638579 0.80 SRC (0.35) CDK4CCND1CDK1CCNB1CCNA2
SCHEMBL13638422 0.79 CDK9 (0.40) CDK4CCND1CDK1CCNB1CCNA2
SCHEMBL14612849 0.79 IKBKB (0.35) CDK4CCND1CDK1CCNB1CCNA2
SCHEMBL13638295 0.79 AKT3 (0.38) CDK4CCND1CDK1CCNB1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed